Sandhya Bangaru

Sandhya Bangaru

I am Sandhya, a fourth year graduate student at Vanderbilt University. I grew up in a beautiful, happening city called Chennai in the south of India. Back home, I majored in biotechnology as an undergraduate and traveled all the way to the city that never sleeps to pursue my masters at NYU. During my masters, I did my thesis work on developing a more stable human Interferon-beta protein for multiple sclerosis treatment. In parallel, I also worked at IAVI as a research assistant, designing and developing a HIV vaccine.

In the course of my research at IAVI, I developed a particular interest in Virology. Vanderbilt was a perfect place to explore this field with a wide variety of research options. I entered Vanderbilt as a part of Vanderbilt international student program. VISP has been a great source of assistance in helping us settle down and also providing constant guidance and support ever since. After my first year, I joined the department of Pathology, Microbiology and Immunology, currently mentored by Dr. James E. Crowe. My research involves isolating and characterizing human monoclonal antibodies against pandemic-potential influenza viruses and determining their cross-reactive potential.


Centers for Excellence in Influenza Research and Surveillance (CEIRS) training grant for $7000



Keitel WA, Jackson LA, Edupuganti S, Winokur PL, Mulligan MJ, Thornburg NJ, Patel SM, Rouphael NG, Lai L, Bangaru S, McNeal MM, Bellamy AR, Hill HR; VTEU H3N2v Vaccine Study Work Group.  Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.  J Infect Dis. 2015 Feb 3. pii: jiv056. [Epub ahead of print]